Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer
about
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsFasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significancesSoluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissuesImmune selection in neoplasia: towards a microevolutionary model of cancer development.Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling.Tumor cell lysate induces the immunosuppression and apoptosis of mouse immunocytes.Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissuesTumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.The immunoregulatory mechanisms of carcinoma for its survival and developmentRETRACTED: Screening of key genes in gastric cancer with DNA microarray analysis.Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancer.Curcumin induces apoptosis in human gastric carcinoma AGS cells and colon carcinoma HT-29 cells through mitochondrial dysfunction and endoplasmic reticulum stress.Immunotherapy in gastrointestinal cancersNeuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease.Helicobacter pylori organisms induce expression of activation and apoptotic surface markers on human lymphocytes and AGS cells: a cytofluorimetric evaluation.In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis.Fas counterattack in cholangiocarcinoma: a mechanism for immune evasion in human hilar cholangiocarcinomas.T cell-mediated cytotoxicity via Fas/Fas ligand signaling in Helicobacter pylori-infected gastric corpus.Molecular mechanisms of H. pylori associated gastric carcinogenesis.Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion.Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.
P2860
Q21328691-9F1D91BC-F6C2-4B09-8E09-3B282E6795A8Q28385359-56DA45F1-BDA0-440E-AE2C-F581DD4D227CQ33599462-2E56B250-1143-451B-AA64-CDA333C6291DQ33730286-FD652572-F6EC-4C48-BAC8-FB8FC677B1A6Q33948688-1ED907E3-05D6-41CB-840A-A4A139582AABQ34056050-8B74D4F6-80F8-4B5F-AE37-E0AA2F765257Q34121359-A187C229-2A87-428E-9498-DE920F7C6E3CQ34487920-FA79F8E7-7714-4236-AE47-8FF5028FD63DQ34592338-9A070FF4-05BD-4711-83F2-39E563471342Q36262150-02EF1254-4599-4ED5-B743-174A45353B1FQ36587186-0CE73180-633C-4618-B23B-8937490C656CQ36643428-16988AE8-6774-4DB7-94DB-8C612A0A15BAQ37736549-2DD2C3CF-F3A1-47CD-B979-ADCB00491B29Q37831426-ED5164BD-1F23-4DA0-B4A6-C73AD399B526Q38312158-B12B8E90-F104-425D-9432-C88B57D3E441Q38715214-D9DB75FE-D6F7-4724-A373-F9E1BDBBCA83Q39121052-0BBCEBB1-0915-4724-BF09-3B619B1EA243Q39453597-A45CAA71-5666-456C-B703-F5E8FE123D81Q40232590-5C7BC790-2EB2-4766-A849-262F76CDF287Q40679707-0E3EF86A-9503-47E7-B5DF-B54F509D6906Q40717883-C4A5E4A8-C85C-4A0F-85F1-F16DA137FDD7Q40749615-527AC148-2090-4C86-9B91-75622E146022Q40751064-7D74D507-003C-4AE8-A623-ADD78AEF6E8AQ41902780-7AEE44D9-A652-4485-9C47-D0B733F5F6A7Q45876454-8C0D7815-83A9-49DA-AA20-F3B05F61E6F5Q53962194-ACA06026-F376-4392-9B25-49435265EC2C
P2860
Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@ast
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@en
type
label
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@ast
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@en
prefLabel
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@ast
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@en
P2093
P2860
P356
P1433
P1476
Expression of Fas ligand by hu ...... mmune escape in stomach cancer
@en
P2093
Bennett MW
Collins JK
O'connell J
O'sullivan GC
Shanahan F
P2860
P304
P356
10.1136/GUT.44.2.156
P407
P577
1999-02-01T00:00:00Z